Challenges in the development and exploitation of new therapeutic options targeting the histaminergic system

Paul L Chazot; Ekaterini Tiligada

doi:10.1111/bph.14947

Challenges in the development and exploitation of new therapeutic options targeting the histaminergic system

Br J Pharmacol. 2020 Feb;177(3):467-468. doi: 10.1111/bph.14947. Epub 2020 Jan 28.

Authors

Paul L Chazot¹, Ekaterini Tiligada²

Affiliations

¹ Department of Biosciences, Durham University, Durham, UK.
² Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Abstract

This article is part of a themed section on New Uses for 21st Century Antihistamines. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.3/issuetoc.

Publication types

Editorial